IT202200004574A1 - N-acetylglucosamine nanoparticles and their applications - Google Patents

N-acetylglucosamine nanoparticles and their applications Download PDF

Info

Publication number
IT202200004574A1
IT202200004574A1 IT102022000004574A IT202200004574A IT202200004574A1 IT 202200004574 A1 IT202200004574 A1 IT 202200004574A1 IT 102022000004574 A IT102022000004574 A IT 102022000004574A IT 202200004574 A IT202200004574 A IT 202200004574A IT 202200004574 A1 IT202200004574 A1 IT 202200004574A1
Authority
IT
Italy
Prior art keywords
acetylglucosamine
nanoparticles
applications
acetylglucosamine nanoparticles
Prior art date
Application number
IT102022000004574A
Other languages
Italian (it)
Inventor
Sergio Ammendola
D'abusco Anna Scotto
Berardis Barbara De
Fabiana Superti
Original Assignee
Sergio Ammendola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sergio Ammendola filed Critical Sergio Ammendola
Priority to IT102022000004574A priority Critical patent/IT202200004574A1/en
Publication of IT202200004574A1 publication Critical patent/IT202200004574A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
IT102022000004574A 2022-03-10 2022-03-10 N-acetylglucosamine nanoparticles and their applications IT202200004574A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102022000004574A IT202200004574A1 (en) 2022-03-10 2022-03-10 N-acetylglucosamine nanoparticles and their applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000004574A IT202200004574A1 (en) 2022-03-10 2022-03-10 N-acetylglucosamine nanoparticles and their applications

Publications (1)

Publication Number Publication Date
IT202200004574A1 true IT202200004574A1 (en) 2023-09-10

Family

ID=83355785

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000004574A IT202200004574A1 (en) 2022-03-10 2022-03-10 N-acetylglucosamine nanoparticles and their applications

Country Status (1)

Country Link
IT (1) IT202200004574A1 (en)

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2252375B1 (en) 2008-02-22 2012-08-08 Sederma Moisturizing cosmetic composition comprising a combination of homarine and erythritol
US8258117B2 (en) 2000-06-29 2012-09-04 Piramal Healthcare (Canada) Ltd Composition and method for the repair and regeneration of cartilage and other tissues
US8361990B2 (en) 2004-04-07 2013-01-29 University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
US20130287853A1 (en) * 2010-11-06 2013-10-31 Marine Polymer Technologies, Inc. Compositions and methods for nanopolymer-based nucleic acid delivery
US8658622B2 (en) 2005-01-14 2014-02-25 Regents Of The University Of California Methods and compositions for preventing and treating a disease related to glycan dysregulation
US8858964B2 (en) 2010-04-15 2014-10-14 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
EP1603529B1 (en) 2003-03-04 2016-04-27 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
US9415036B2 (en) 2008-02-15 2016-08-16 Bone Therapeutics Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
US9446065B2 (en) 2008-02-15 2016-09-20 Bone Therapeutics Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
US9801829B2 (en) 2011-04-29 2017-10-31 University Of Florida Research Foundation, Inc. Methods and systems of making nanostructures
US9937134B2 (en) 2007-01-30 2018-04-10 Cypress Pharmaceuticals, Inc. Hyaluronate compositions
US20190185502A1 (en) 2017-12-18 2019-06-20 Risen (Suzhou) Pharma Tech Co., Ltd. Glucosamine derivatives and pharmaceutical uses thereof
US10412960B2 (en) 2012-04-06 2019-09-17 Centre National De La Recherche Scientifique Microparticles and nanoparticles made up of hydrophobized polysaccharides and an alpha-cyclodextrine
US10532069B2 (en) 2015-01-20 2020-01-14 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US10583161B2 (en) 2014-06-16 2020-03-10 Unigen, Inc. Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258117B2 (en) 2000-06-29 2012-09-04 Piramal Healthcare (Canada) Ltd Composition and method for the repair and regeneration of cartilage and other tissues
EP1603529B1 (en) 2003-03-04 2016-04-27 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
US8361990B2 (en) 2004-04-07 2013-01-29 University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
US8658622B2 (en) 2005-01-14 2014-02-25 Regents Of The University Of California Methods and compositions for preventing and treating a disease related to glycan dysregulation
US9775859B2 (en) 2005-01-14 2017-10-03 Sinai Health System Methods and compositions for preventing and treating a disease related to glycan dysregulation
US9937134B2 (en) 2007-01-30 2018-04-10 Cypress Pharmaceuticals, Inc. Hyaluronate compositions
US9415036B2 (en) 2008-02-15 2016-08-16 Bone Therapeutics Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
US9446065B2 (en) 2008-02-15 2016-09-20 Bone Therapeutics Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
US9872876B2 (en) 2008-02-15 2018-01-23 Bone Therapeutics Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
EP2252375B1 (en) 2008-02-22 2012-08-08 Sederma Moisturizing cosmetic composition comprising a combination of homarine and erythritol
US9198928B2 (en) 2010-04-15 2015-12-01 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US8858964B2 (en) 2010-04-15 2014-10-14 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US10206938B2 (en) 2010-04-15 2019-02-19 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US20130287853A1 (en) * 2010-11-06 2013-10-31 Marine Polymer Technologies, Inc. Compositions and methods for nanopolymer-based nucleic acid delivery
US9801829B2 (en) 2011-04-29 2017-10-31 University Of Florida Research Foundation, Inc. Methods and systems of making nanostructures
US10412960B2 (en) 2012-04-06 2019-09-17 Centre National De La Recherche Scientifique Microparticles and nanoparticles made up of hydrophobized polysaccharides and an alpha-cyclodextrine
US10583161B2 (en) 2014-06-16 2020-03-10 Unigen, Inc. Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof
US10532069B2 (en) 2015-01-20 2020-01-14 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US20190185502A1 (en) 2017-12-18 2019-06-20 Risen (Suzhou) Pharma Tech Co., Ltd. Glucosamine derivatives and pharmaceutical uses thereof

Non-Patent Citations (16)

* Cited by examiner, † Cited by third party
Title
CHEN J.-K.SHEN C.-R.LIU C.-L.: "N-Acetylglucosamine: Production and applications", MAR. DRUGS, vol. 8, 2010, pages 2493 - 2516, XP055951489, DOI: 10.3390/md8092493
KLATT ANDREAS R.PAUL-KLAUSCH BKLINGER G.KUHN G.RENNO JOERG H.BANERJEE M.MALCHAU G.WIELCKENS K.: "A Criticai role for collagen II in Cartilage Matrix degradation: Collagen II Induces Pro-Inflammatory cytokines and MMPs in Primary Human chondrocytes", J. ORTH. RES., 2009, pages 65 - 70
LAMBERT CZAPPIA J.SANCHEZ CFLORIN A.DUBUC J.-E.HENROTIN Y.: "the damage-associated molecular patterns (Damps) as potential targets to treat osteoarthritis: Species from a Review of the Literature", FRONT. MED., 18 January 2021 (2021-01-18)
MORTALES C.-L.LEE S.-L.MANOUSADJIAN A.HAYAMA K.L.DEMETRIOU M.: "N-Glycan Branching Decouples B Cell innate and Adaptive Immunity to Control inflammatory demyelination", SCIENCE, vol. 23, 21 August 2020 (2020-08-21), pages 101380
MOUSSIAN B.: "the role of GlcNAc in formation and function of extracellular matrices", COMP. BIOCH. PHYSIOLOGY, PART B, vol. 149, 2008, pages 215 - 226, XP022402715
NANDAKUMAR K.S.BUCKLUND J.VESTBERG M.HOLMDAHL R.: "collagen type II (Cll)-specific antibodies induces arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells", ARTHRITIS RESEARCH & THERAPY, vol. 6, no. 6, 2004, pages R544 - R550
NASHCHEKINA Y.NIKONOV P.MIKHAILOVA N.NASHCHEKIN A: "collagen scaffolds treated by hydrogen Peroxide for Cell Culture", POLYMERS, vol. 13, 2021, pages 4134
OESSER S.SEIFERT J.: "stimulation of type II collagen biosynthesis and secretion in bovine bonds cultured with degraded collagen", CELI TISSUE RES, vol. 311, 2003, pages 393 - 399, XP002254608
PERSIANI S.RODA E.ROVATI L. C.LOCATELLI M.GIACOVELLI G.RODA A.: "Glucosamine orai bioavailability and plasma pharmacokinetics after increasing doses of cystalline glucosamine sulfate in man", OSTEOARTHRITIS AND CARTILAGE, vol. 13, 2005, pages 1041 - 1049
RYCZKO M.C., PAWLING J., CHEN R., ABDEL RAHMAN A.M., YAU K., COPELAND J.K., ZHANG C., SURENDRA A., GUTTMAN D.S., FIGEYS D. & DENNI: "metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways", SCIENTIFIC REPORTS, vol. 6, pages 23043
SHEBEKO S. K.ZUPANETS I. A.POPOV O. S.: "N-Acetylglucosamine is the most effective glucosamine derivative for the treatment of membrane nephropathy in rats", PHARMATICS, vol. 74, 2019, pages 667 - 670
STOPPOLONI D.POLITI LLEOPIZZI M.GAETANI S.GUAZZO R.BASCIANI S.MORESCHINI 0.DE SANTI M.SCANDURRA R.SCOTTO D'ABUSCO A.: "Effect of glucosamine and its peptidyll-derivative on the production of extracellular matrix components by human primary chondrocytes", OSTEOARTHRITIS AND CARTILAGE, vol. 23, no. 1, 2015, pages 103 - 113, XP055346705, DOI: 10.1016/j.joca.2014.09.005
SY M.BRANDT A.U.LEE S.KNEWTON B.L.PAWLING J.GOLZAR A.RAHMAN ANAS M.A.YU Z.COOPER G.SCHEEL M.: "N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor celi differentiation", J. BIOL. CHEM., vol. 295, no. 51, 2020, pages 17413 - 17424
SY M.BRANDT A-U.LEE S.-U.NEWTON B.L.PAWLING J.GOLZAR A.RAHMAN ANAS M. A.YU Z.COOPER G.SCHEEL M.: "Monomeric, porous type II collagen scaffolds promote chondrogenic differentiation of human bone marrow mesenchymal stem cells in vitro", SCIENTIFIC REPORTS, vol. 17, pages 435191
TOMONAGA A.WATANABE K.FUKAGAWA M.SUZUKI A.KUROKAWA M.NAGAOKA I.: "Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for carthage metabolism in healthy identified without symptoms of arthritis: A randomized double-blind placebo-controlled clinical study", EXP. THERAP. MED, vol. 12, 2016, pages 1481 - 1489
ZHANG XUE-NONG ET AL: "Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS", INTERNATIONAL JOURNAL OF NANOMEDICINE, vol. 2012, 30 March 2012 (2012-03-30), pages 1723 - 1723, XP093009336, Retrieved from the Internet <URL:https://www.dovepress.com/getfile.php?fileID=12436> DOI: 10.2147/IJN.S29696 *

Similar Documents

Publication Publication Date Title
DK3630917T3 (en) UNIFORMLY ENCAPSULATED NANOPARTICLES AND THEIR APPLICATIONS
MA52074A (en) NEW PROGRAMMABLE RNA ENDONUCLEASE SYSTEMS AND THEIR USES
MA45034A (en) METHOD OF MANUFACTURING A BRASS BILLET WITHOUT LEAD OR LOW LEAD
IT202200004574A1 (en) N-acetylglucosamine nanoparticles and their applications
FR3046951B1 (en) PROCESS FOR MANUFACTURING A PIECE OF A TURBOMACHINE AND PIECE PRODUCED THEREBY
IT201700103511A1 (en) MICROELECTRONIC DEVICE EQUIPPED WITH PROTECTED CONNECTIONS AND RELATIVE PROCESS OF MANUFACTURE
IT201900024775A1 (en) STRUCTURE OF THE BOTTOM AND ITS APPLICATIONS ON SPORTSWEAR
ITTO20130670A1 (en) CELLULOSIC SUBSTRATE WITH ANTI-FLAME PROPERTIES AND RELATED PRODUCTION PROCEDURE
ES1296440Y (en) classification provision
IT201900020642A1 (en) WINDOW STRUCTURE AND RELATIVE ASSEMBLY METHOD
JP2017063089A5 (en)
JP1767477S (en) Particle Processing Equipment
PL27792S2 (en) Electronic cashier
PL27344S2 (en) Website
UA44411S (en) MICROMETER
TH2102004621S (en) Cross section
TH2102003861A (en) Cross section
TH2102003861S (en) Cross section
TH2102003413S (en) Cross section
TH2102002096S (en) metal cross section
TH2102002095S (en) metal cross section
TH2102002094S (en) metal cross section
IT201900022890A1 (en) STRUCTURE OF GUITAR AND RELATED MANUFACTURING PROCESS
TWI800294B (en) Silver powder and its manufacturing method
TWI842210B (en) Selective PARP1 inhibitors and their applications